| Blood-based analysis of 84 microRNAs identifies molecules deregulated in individuals with type-2 diabetes, risk factors for the disease or metabolic syndrome M Avgeris, I Kokkinopoulou, E Maratou, P Mitrou, E Boutati, A Scorilas, ... Diabetes Research and Clinical Practice 164, 108187, 2020 | 21 | 2020 |
| Decreased expression of microRNAs targeting type-2 diabetes susceptibility genes in peripheral blood of patients and predisposed individuals I Kokkinopoulou, E Maratou, P Mitrou, E Boutati, DC Sideris, EG Fragoulis, ... Endocrine 66, 226-239, 2019 | 46 | 2019 |
| Blood-based analysis of type-2 diabetes mellitus susceptibility genes identifies specific transcript variants with deregulated expression and association with disease risk MI Christodoulou, M Avgeris, I Kokkinopoulou, E Maratou, P Mitrou, ... Scientific reports 9 (1), 1512, 2019 | 37 | 2019 |
| Behavior Targeting Based on Hierarchical Taxonomy Aggregation for Heterogeneous Online Shopping Applications L ZHANG, C ZHANG, Z HU, X TANG ZTE Communications 16 (1), 52, 2018 | | 2018 |
| Investigation of the peripheral blood gene-expression signature in patients with type-2 diabetes mellitus, using mRNA next-generation sequencing MI Christodoulou, M Avgeris, K Kokkinopoulou, E Maratou, P Mitrou, ... FEBS JOURNAL 283, 70-70, 2016 | | 2016 |
| Clinical evaluation of microRNA-145 expression in renal cell carcinoma: a promising molecular marker for discriminating and staging the clear cell histological subtype EI Papadopoulos, C Petraki, A Gregorakis, EG Fragoulis, A Scorilas Biological Chemistry 397 (6), 529-539, 2016 | 19 | 2016 |
| Evidence for the implication of human DDC and carbidopa in human cancer cell viability ED Kalantzis, A Scorilas, EG Fragoulis, D Vassilacopoulou | | 2016 |
| L-Dopa decarboxylase (DDC) mRNA expression: implication in insulin-signaling in human beta-pancreatic cells DS Tounta, E Maratou, A Scorilas, EG Fragoulis, MI Christodoulou FEBS JOURNAL 282, 161-162, 2015 | | 2015 |
| Study of the expression of 28 diabetes-related genes in peripheral blood: indications for clinical significance in type 2 diabetes mellitus (T2DM) MI Christodoulou, M Avgeris, IK Kokkinopoulou, E Boutati, E Maratou, ... FEBS JOURNAL 282, 162-162, 2015 | | 2015 |
| L-DOPA decarboxylase mRNA levels provide high diagnostic accuracy and discrimination between clear cell and non-clear cell subtypes in renal cell carcinoma EI Papadopoulos, C Petraki, A Gregorakis, E Chra, EG Fragoulis, ... Clinical Biochemistry 48 (9), 590-595, 2015 | 11 | 2015 |
| Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment M Avgeris, K Mavridis, T Tokas, K Stravodimos, EG Fragoulis, A Scorilas Carcinogenesis 36 (5), 528-537, 2015 | 81 | 2015 |
| Human L-DOPA decarboxylase mRNA is a target of miR-145: a prediction to validation workflow EI Papadopoulos, EG Fragoulis, A Scorilas Gene 554 (2), 174-180, 2015 | 7 | 2015 |
| Uncovering the dual clinical value of miR-143/145 cluster in bladder cancer epithelium and patients survival outcome M Avgeris, T Tokas, K Stravodimos, EG Fragoulis, A Scorilas FEBS JOURNAL 281, 275-276, 2014 | | 2014 |
| Evidence for anti-proliferative properties of the anti-diabetic agent 1, 1-dimethylbiguanide hydrochloride (metformin) on human ovarian cancer cells MI Christodoulou, P Samara, O Tsitsilonis, E Fragoulis, A Scorilas FEBS JOURNAL 281, 463-464, 2014 | | 2014 |
| Study of the expression pattern of L-Dopa decarboxylase (DDC) in human beta-pancreatic cells: indications of involvement in the insulin-biosynthesis pathway MI Christodoulou, E Maratou, G Pantoleon, CD Zorba, A Scorilas, ... FEBS JOURNAL 281, 602-602, 2014 | | 2014 |
| Evidence for the implication of L-Dopa decarboxylase in apoptosis AC Tsakou, I Chalatsa, EG Fragoulis, D Vassilacopoulou FEBS JOURNAL 280, 429-429, 2013 | | 2013 |
| L-DOPA decarboxylase (DDC) upregulation correlates with aggressive breast and prostate tumors, representing a novel biomarker for the accurate prognosis of breast and prostate … K Michaelidou, M Avgeris, A Scorilas, EG Fragoulis FEBS JOURNAL 280, 323-323, 2013 | | 2013 |
| The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients M Avgeris, K Stravodimos, EG Fragoulis, A Scorilas British journal of cancer 108 (12), 2573-2581, 2013 | 111 | 2013 |
| Quantification and study of the L-DOPA decarboxylase expression in gastric adenocarcinoma cells treated with chemotherapeutic substances D Korbakis, EG Fragoulis, A Scorilas Anti-Cancer Drugs 24 (3), 291-299, 2013 | 5 | 2013 |
| l-Dopa decarboxylase (DDC) constitutes an emerging biomarker in predicting patients’ survival with stomach adenocarcinomas D Florou, IN Papadopoulos, EG Fragoulis, A Scorilas Journal of cancer research and clinical oncology 139, 297-306, 2013 | 13 | 2013 |
Andreas ScorilasProfessor of Clinical Biochemistry, National and Kapodistrian University of AthensVerified email at biol.uoa.gr